Advanced glycation end products enhance reactive oxygen and nitrogen species generation in neutrophils in vitro
- 415 Downloads
Increased oxidative stress (OS) in diabetes mellitus is one of the major factors leading to diabetic pathology. However, the mediators and mechanism that provoke OS in diabetes is not fully understood, and it is possible that accumulation of advanced glycation end products (AGEs) formed secondary to hyperglycemic conditions may incite circulating polymorphonuclear neutrophils (PMN) to generate reactive oxygen species (ROS). In this report, we aim to investigate the effect of AGE on reactive oxygen and nitrogen species generation and subsequent OS in PMN. AGE-HSA exert dose- and time-dependent enhancement of ROS and reactive nitrogen intermediates (RNI) generation by PMN. Increased ROS and RNI generation were found to be mediated through the upregulation of NADPH oxidase and inducible nitric oxide synthase (iNOS), respectively, as evident from the fact that AGE-treated neutrophils failed to generate ROS and RNI in presence of diphenyleneiodonium, a flavoprotein inhibitor for both enzymes. Further increased generation of ROS and RNI ceased when the cells were incubated with anti-RAGE antibody suggesting the involvement of AGE–RAGE interaction. Also increased malondialdehyde (MDA) and protein carbonyl formation in AGE-exposed PMN suggest induction of OS by AGE. This study provides evidence that AGEs may play a key role in the induction of oxidative stress through the augmentation of PMN-mediated ROS and RNI generation and this may be in part responsible for development of AGE-induced diabetic pathology.
KeywordsAdvanced glycation end products Polymorphonuclear neutrophil NADPH oxidase Inducible nitric oxide synthase Protein carbonyl Malondialdehyde Diphenyleneiodonium Reactive oxygen and nitrogen species
This work is supported through a project funded by Indian Council of Medical research and one of the authors Savita Bansal is thankful to Council of Scientific and Industrial Research (CSIR), New Delhi, India for providing Junior Research Fellowship (NET). Authors are thankful to Prof. Rina Chakrabarti, Department of Zoology, University of Delhi and Dr. Sudip Dutta for providing necessary help in spectrofluorometric assays and manuscript editing, respectively.
- 7.Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD (2011) Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes. Diabetes Care 34:442–447PubMedCrossRefGoogle Scholar
- 12.Folli F, Corradi D, Fanti P, Davalli A, Paez A, Giaccari A, Perego C, Muscogiuri G (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev. (Epub ahead of print)Google Scholar
- 14.Karima M, Kantarci A, Ohira T, Hasturk H, Jones VL, Nam BH, Malabanan A, Trackman PC, Badwey JA, Van Dyke TE (2005) Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis. J Leukoc Biol 78:862–870PubMedCrossRefGoogle Scholar
- 26.Wong RKM, Pettit AI, Quinn PA, Jennings SC, Davies JE, Leong L Ng (2003) Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid. Circulation 108:1858–1864PubMedCrossRefGoogle Scholar